Who is sponsoring NCT02651311?

NCT02651311 is sponsored by Ajou University School of Medicine.

What drugs are being tested in NCT02651311?

Interventions in NCT02651311: intermediate cervical plexus block, Fentanyl, Ibuprofen.

What condition does NCT02651311 study?

NCT02651311 studies Congenital Muscular Torticollis.

Is NCT02651311 still recruiting?

NCT02651311 is currently completed. Last updated 27 January 2017.

Last reviewed 2017-01-27 · How we verify

NCT02651311

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasound Guided Intermediate Cervical Plexus Block for Congenital Muscular Torticollis

Completed Phase 4 Last updated 27 January 2017

What this trial tests

Phase 4 trial testing intermediate cervical plexus block in Congenital Muscular Torticollis in 32 participants. Completed in 15 December 2016.

Timeline

16 January 2016

Primary endpoint
15 December 2016

15 December 2016

Quick facts

Lead sponsor	Ajou University School of Medicine
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	32
Start date	16 January 2016
Primary completion	15 December 2016
Estimated completion	15 December 2016
Sites	1 location across South Korea

Drugs / interventions tested

intermediate cervical plexus block
Fentanyl (fentanyl) — full drug profile →
Ibuprofen (ibuprofen) — full drug profile →

Conditions studied

Congenital Muscular Torticollis — all drugs for Congenital Muscular Torticollis →

Sponsor

Ajou University School of Medicine

Who can join

Adults 1 to 7, any sex, with Congenital Muscular Torticollis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Congenital Muscular Torticollis (CMT) is a postural deformity of head and neck detected at birth or shortly after birth, primarily resulting from unilateral shortening of Sternocleidomastoid Muscle (SCM). Surgery could be chosen for the treatment for some children, which is accompanied by moderate pain and discomfort. The investigators focused the effectiveness of intermediates cervical plexus block because the dermatome of sensory of cervical plexus block is correlated to that of torticollis. So the effect of analgesia could decrease the use of analgesics.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Postoperative Analgesic Effect of Ultrasound-Guided Intermediate Cervical Plexus Block on Unipolar Sternocleidomastoid Release With Myectomy in Pediatric Patients With Congenital Muscular Torticollis: A Prospective, Randomized Controlled Trial.
Kim JS, Joe HB, Park MC, Ahn H, et al · · 2018 · cited 10× · PMID 29781932 · DOI 10.1097/aap.0000000000000797

Verify or expand the search:

Other trials of intermediate cervical plexus block

Trials testing the same drug.

NCT05577559 — Ultrasound-Guided Intermediate Cervical Plexus or Cervical Erector Spinae Block for Anterior Cervical Spine Surgery · NA · completed

Other recruiting trials for Congenital Muscular Torticollis

Currently open trials in the same condition.

NCT05917678 — Effectiveness of Repositioning and Cranial Remolding in Infants With Cranial Deformation · NA · recruiting

Other Ajou University School of Medicine trials

Trials by the same sponsor.

NCT07101380 — Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients · NA · recruiting
NCT07395752 — Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study · NA · recruiting
NCT06964217 — Immediate Fracture Risk After Antihypertensive Drug Initiation · not yet recruiting
NCT05751603 — Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex · NA · not yet recruiting
NCT07479160 — Heart to Heart Web-based Communication Program for Heart Failure · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02651311 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ajou University School of Medicine
Last refreshed: 27 January 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02651311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing